Technique may speed drug production, reduce costs and waste
Main Category: Pharma Industry / Biotech IndustryArticle Date: 20 Apr 2005 - 0:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
University of Toronto researchers have a developed a new chemical reaction that could greatly accelerate pharmaceutical production, while also cutting costs and toxic by-products.
The reaction, designed by chemistry Professor Mark Lautens and graduate student Eric Fang, simplifies the creation of the basic molecular framework found in many natural products and popular pharmaceuticals like some cholesterol-lowering drugs. Until now, synthesizing this framework - an indole - was inefficient, requiring six to 10 steps and often producing toxic by-products. "This new method only takes three steps and results in less waste," says Lautens, the NSERC-Merck Frosst Industrial Research Chair in New Medicinal Agents via Catalytic Reactions and AstraZeneca Professor of Organic Synthesis.
Indoles are ring structures containing carbon and nitrogen. In the process, the researchers used a metallic element as a catalyst to form two chemical bonds and create a diverse range of indole-containing compounds. These compounds could then be used to make drugs now on the market or form the basis of new therapeutic drugs.
Lautens says this new molecular-level technique could equal big savings and less environmental impact. "In order to make a hundred kilograms of these best-selling drugs, there are often hundreds of litres of solvent used, not to mention the many purification processes involved. Not only are you speeding up the process, you're also reducing waste and energy used in manufacturing."
A provisional patent was filed by U of T's Innovations Foundation in March. The research was funded by the Natural Sciences and Engineering Research Council of Canada.
CONTACT: Professor Mark Lautens, U of T Department of Chemistry, 416-978-6083, mlautens@chem.utoronto.ca, or Karen Kelly, U of T Public Affairs, 416-978-6974, k.kelly@utoronto.ca
For the latest U of T news, visit the news and events website at: http://www.utoronto.ca For U of T experts, see the Blue Book Online at: http://www.library.utoronto.ca/bluebook
Contact: Prof. Mark Lautens
416-978-6083
University of Toronto
http://www.utoronto.ca
Visit our pharma industry / biotech industry section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/23082.php>
APA
http://www.medicalnewstoday.com/releases/23082.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



